Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bengt Glimelius

Showing results (11-20 of 431) with videos related to

Pageof 44
Sort By:
Drug Safety|April 28, 2005
Benefit-risk assessment of irinotecan in advanced colorectal cancerBengt Glimelius
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
50 years with Acta OncologicaBengt Glimelius
Nature Clinical Practice. Oncology|November 3, 2005
Adjuvant chemotherapy in rectal cancers: why a standard in the US and not in Europe?Bengt Glimelius
British Medical Bulletin|November 8, 2002
Radiotherapy in rectal cancerBengt Glimelius
The Lancet. Oncology|July 20, 2015
Is the benefit of oxaliplatin in rectal cancer clinically relevant?Bengt Glimelius
Digestive Surgery|May 22, 2003
Role of adjuvant chemoradiotherapy for abdominal malignanciesBengt Glimelius
Acta Oncologica (Stockholm, Sweden)|May 28, 2004
Long-term sequelae after cancer therapy--a necessary consequence of success?Bengt Glimelius
Frontiers in Oncology|April 30, 2014
Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer?Bengt Glimelius
Upsala Journal of Medical Sciences|March 7, 2024
Recent advances in rectal cancer treatment - are we on the right track?Bengt Glimelius
Acta Oncologica (Stockholm, Sweden)|April 20, 2010
Any progress in pancreatic cancer? Well, but progress for Acta OncologicaBengt Glimelius
Pageof 44

Showing results (11-20 of 431) with videos related to

Sort By:
Pageof 44
Drug Safety|April 28, 2005
Benefit-risk assessment of irinotecan in advanced colorectal cancerBengt Glimelius
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
50 years with Acta OncologicaBengt Glimelius
Nature Clinical Practice. Oncology|November 3, 2005
Adjuvant chemotherapy in rectal cancers: why a standard in the US and not in Europe?Bengt Glimelius
British Medical Bulletin|November 8, 2002
Radiotherapy in rectal cancerBengt Glimelius
The Lancet. Oncology|July 20, 2015
Is the benefit of oxaliplatin in rectal cancer clinically relevant?Bengt Glimelius
Digestive Surgery|May 22, 2003
Role of adjuvant chemoradiotherapy for abdominal malignanciesBengt Glimelius
Acta Oncologica (Stockholm, Sweden)|May 28, 2004
Long-term sequelae after cancer therapy--a necessary consequence of success?Bengt Glimelius
Frontiers in Oncology|April 30, 2014
Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer?Bengt Glimelius
Upsala Journal of Medical Sciences|March 7, 2024
Recent advances in rectal cancer treatment - are we on the right track?Bengt Glimelius
Acta Oncologica (Stockholm, Sweden)|April 20, 2010
Any progress in pancreatic cancer? Well, but progress for Acta OncologicaBengt Glimelius
Pageof 44